Difference in transducin-like enhancer of split 1 protein expression between basal cell adenomas and basal cell adenocarcinomas - an immunohistochemical study

• Egile Nagusiak: Yuzo Oyama (Egilea), Haruto Nishida (Egilea), Takahiro Kusaba (Egilea), Hiroko Kadowaki (Egilea), Motoki Arakane (Egilea), Junpei Wada (Egilea), Shogo Urabe (Egilea), Takashi Hirano (Egilea), Kenji Kawano (Egilea), Masashi Suzuki (Egilea), Shigeo Yokoyama (Egilea), Tsutomu Daa (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2018-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Basal cell adenoma (BCA) and basal cell adenocarcinoma (BCAC) are benign and malignant, basaloid salivary gland neoplasms, respectively. These tumors show a dual-cell proliferation of inner luminal/ductal cells and outer abluminal/myoepithelial or basal cells. The only difference...